Abstract: The present invention relates to a method for predicting the neurological outcome of a patient after cardiac arrest, the method comprising the step(s) of: (I) a) determining the level of alpha-enolase in a biological sample obtained from a patient after cardiac arrest; and b) comparing the level of alpha-enolase obtained in (a) with the median or mean level of alpha-enolase in biological samples from patients with positive neurological outcome after cardiac arrest, wherein said patient is diagnosed as having a negative neurological outcome if the alpha-enolase level is increased by at least 100% over the median or mean level of alpha-enolase, and/or a positive neurological outcome if the alpha-enolase level is below 150% as compared to the median or mean level of alpha-enolase; or (II) determining the level of alpha-enolase in a biological sample obtained from a patient after cardiac arrest, wherein said patient is diagnosed as having a negative neurological outcome if the alpha-enolase level is above 50 ?g/L

Abstract: An apparatus and a method for analysing a solid specimen material by means of ablating particles of the solid specimen material by laser into a carrier liquid, having: a specimen holder for arranging the solid specimen material covered by the carrier liquid, a laser apparatus for irradiating the solid specimen material to produce a suspension of particles of the solid specimen material and the carrier liquid, an analysis apparatus for analysing the particles, an ablation cell with the specimen holder, having a liquid channel for the carrier liquid and having an entry window made of a material that transmits the laser beam, a supply line for supplying the carrier liquid into the liquid channel of the ablation cell and a discharge line for discharging the suspension of particles of the solid specimen material and the carrier liquid from the liquid channel of the ablation cell into the analysis apparatus.

Abstract: Methods and apparatus for designing a skull prosthesis are disclosed. In one arrangement, imaging data from a medical imaging process is received. The imaging data represents the shape of at least a portion of a skull. The imaging data is used to display on a display device a first virtual representation of at least a portion of the skull. User input defining a cutting line in the first virtual representation is received. A surgical operation of cutting through the skull along at least a portion of the defined cutting line to at least partially disconnect a target portion of the skull from the rest of skull is simulated. Output data is provided based on the simulation. The output data represents a simulated shape of at least a portion of the skull with the target portion at least partially disconnected from the rest of the skull, thereby defining the shape of an implantation site for a skull prosthesis to be manufactured.

Abstract: The invention relates to a device for the representation of tactile characters, in particular in Braille, comprising tactile elements which are combined in groups, wherein a tactile character consists in each case of a matrix of tactile points, which can be arranged in two adjacently arranged columns of points and at least two lines of points, wherein the four possible combinations of two tactile points of tactile points arranged adjacently in a line of points are in each case arranged on a common tactile element.

Abstract: The present invention relates to a microfluidic device for creating within a cell assembly a cell-free area, comprising at least one cell chamber, wherein the at least one cell chamber comprises: —a fluid inlet for introducing fluid into the cell chamber, —a first area, —a second area, —at least one mechanical excluding means for excluding cells from the first area of the chamber and being operable between an excluding position and a releasing position optionally via an actuation line, wherein the second area of the cell chamber is outside of the operation range of the mechanical excluding means.

Abstract: Radically polymerizable composition which contains at least one vinyl ether according to general formula I:

Abstract: The present invention is directed to a compound for use in the prevention or treatment of a neurodegenerative disease, in particular of a synucleinopathy. The present invention further is directed to a pharmaceutical composition containing an effective amount of said compound and one or more pharmaceutically acceptable auxiliaries.

Abstract: The invention relates to a method for producing lignin particles, comprising the steps of: a) extracting lignin from a lignincontaining starter material, using a mixture that comprises at least one organic solvent and water, and b) precipitating the lignin in the solution from step a).

Abstract: A first arch and second arch are produced in respective first and second structural portions. Each arch has a tie rod interconnecting the foot points of the arch, where a foot point of the arch is displaceably mounted. Each tie rod is tensioned so that horizontal forces caused by the weight of the arches at the foot points of the corresponding arch, are taken up by the tie rods. A first end point of the tie rod of the first arch is connected in a force-fitting manner to the first abutment, and a second end point of the tie rod of a last arch is connected in a force-fitting manner to the second abutment. The remaining adjoining end points of the tie rods are connected to one another in a force-fitting manner, and corresponding foot points of the arches are connected in a force-fitting manner to the abutments and pillar.

Abstract: A spindle arrangement for a machine tool, comprising a spindle for driving a tool and at least one actuator for exciting vibration of the tool, characterized in that the spindle arrangement is provided with a compensation device for at least partly compensating the inertia forces produced by the vibration excitation in the spindle region.

Abstract: A method to assess the distribution of electronic files within provider networks, wherein each provider network includes at least one server computer which distributes the electronic files to a multitude of client computers within the provider network. The present teaching also relates to an electronic data analysis device and a system for implementing such a method.

Abstract: Method and system for executing a one-time program comprising at least one instruction operating on at least one input value (a, b) and returning at least one output value (O), wherein each instruction of the one-time program is encoded onto a state of an elementary quantum system, comprising: encoding the at least one input value (a, b) onto a quantum gate according to a pre-defined input-encoding scheme; applying the quantum gate to the at least one elementary quantum system; making a measurement of a resulting state of the at least one elementary quantum system after the quantum gate; and determining the at least one output value from a result of the measurement.

Abstract: The present invention relates to a vaccine composition V comprising a peptidic entity A comprising one or more sequence motifs A1 of the sequence RR-X1a-X1b-L (SEQ ID NO: 23) wherein X1a is a hydrophobic amino acid moiety and X1b is a peptide bond or a hydrophobic amino acid moiety, or an analogue thereof, an antigen of interest B and silica particles C embracing A and B. Further, the present invention relates to the peptidic entity A usable for such purpose and pharmaceutical and non-pharmaceutical uses of the vaccine composition V.

Abstract: The present invention relates to a mutant thymidine kinase, specifically a mutant human thymidine kinase 1 (Tkl1). The activity of the mutant thymidine kinase is increased compared to the activity of wildtype thymidine kinase. Provided herein are uses of the mutant thymidine kinase in therapy, such as in cancer therapy. Also methods of treating cancer comprising administering the mutant thymidine kinase are disclosed herein. The present invention relates, inter alia, to a nucleic acid for use hi treating cancer, wherein said nucleic acid comprises a nucleotide sequence, wherein said nucleotide sequence encodes a mutant thymidine kinase.

Abstract: The present invention relates to a method and a device for a nucleic acid based diagnostic approach including the determination of a deviant condition of a sample, wherein the deviant condition is preferably a health condition and/or a pathogenic condition.

Abstract: The present invention relates to novel monomaleimide-functionalized platinum compounds of formula (I), including in particular novel monomaleimide-functionalized oxaliplatin and carboplatin derivatives, as well as their use as medicaments, particularly for the treatment or prevention of cancer.

Abstract: The present invention is directed to a compound for use in the prevention or treatment of a neurodegenerative disease, in particular of a synucleinopathy. The present invention further is directed to a pharmaceutical composition containing an effective amount of said compound and one or more pharmaceutically acceptable auxiliaries.

Abstract: The present invention relates to a method for assessing whether a patient suffers from cancer, such as hepatocellular carcinoma, or is prone to suffering from cancer, such as hepatocellular carcinoma, wherein said method comprises determining the amount of soluble AXL in a sample from the patient. The patient is assessed to suffer from cancer or to be prone to suffering from cancer when the amount of soluble AXL is increased in comparison to a control. The present invention relates to the use of soluble AXL for assessing whether a patient suffers from cancer, such as hepatocellular carcinoma, or is prone to suffering from cancer, such as hepatocellular carcinoma. Also a kit for use in the methods of the present invention is provided.

Abstract: Radically polymerizable silane according to the general formula I in which R1 is a linear or branched aliphatic C1-C9-alkyl radical, phenyl or alkylated phenyl radical, R2, R3 independently of each other in each case are absent or are a linear or branched aliphatic C1-C20-alkylene radical, which can be interrupted by S or O atoms, R4, R5, R6 independently of each other in each case are —Cl, —O—CH3, —O—C2H5, —CH3 or —C2H5, X is CH2 or O, Y is absent, or is O or NR?, wherein R? is H or a C1-5-alkyl radical, and Z is absent, or is O, NR?, —CO—O—, —CO—NR?—, —O—CO—O—, —O—CO—NR?—, or —NR?—CO—NR?—, wherein R? is H or a C1-5-alkyl radical and wherein the radicals R2 and R3 cannot be absent at the same time and Z is absent if R2 or R3 is absent, polycondensates based thereon and fillers surface-modified therewith.

Abstract: Radically polymerizable dental material, which contains at least one sulphonic acid ester of Formula 1: in which A is H, CN, an aromatic, cycloaliphatic, linear or branched aliphatic C1-C30-hydrocarbon radical or a combination thereof; X is COO— or —CON(R1)— or is absent; B is an aromatic, cycloaliphatic, linear or branched aliphatic C1-C30-hydrocarbon radical, or a combination thereof; R1 is hydrogen or an aromatic, cycloaliphatic, linear or branched aliphatic C1-C10-hydrocarbon radical; m is an integer from 1 to 6, n is an integer from 1 to 6 and p is an integer from 1 to 6; wherein m and p cannot simultaneously be greater than 1. The compounds of Formula 1 are active as chain transfer agents in radical polymerization.